Nucleic acid sequences and fusion proteins present in human t(2;5) lymphoma
US5529925A · kind A · utility
37Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 1993 |
| Grant date | Jun 25, 1996 |
| Priority date | — |
| Expiry date | Dec 3, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/81
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention is based on the identification and sequence determination of fusion proteins generated by translocation which is present in t(2:5) lymphoma cells. Using either the amino acid or nucleic acid sequences of the fusion proteins disclosed herein, the present invention provides methods of detecting and treating t(2;5) lymphoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.